Literature DB >> 27727458

Relationship between mutant Cu/Zn superoxide dismutase 1 maturation and inclusion formation in cell models.

Jacob I Ayers1, Benjamin McMahon1, Sabrina Gill1, Herman L Lelie2, Susan Fromholt1, Hilda Brown1, Joan Selverstone Valentine2, Julian P Whitelegge3, David R Borchelt1.   

Abstract

A common property of Cu/Zn superoxide dismutase 1 (SOD1), harboring mutations associated with amyotrophic lateral sclerosis, is a high propensity to misfold and form abnormal aggregates. The aggregation of mutant SOD1 has been demonstrated in vitro, with purified proteins, in mouse models, in human tissues, and in cultured cell models. In vitro translation studies have determined that SOD1 with amyotrophic lateral sclerosis mutations is slower to mature, and thus perhaps vulnerable to off-pathway folding that could generate aggregates. The aggregation of mutant SOD1 in living cells can be monitored by tagging the protein with fluorescent fluorophores. In this study, we have taken advantage of the Dendra2 fluorophore technology in which excitation can be used to switch the output color from green to red, thereby clearly creating a time stamp that distinguishes pre-existing and newly made proteins. In cells that transiently over-express the Ala 4 to Val variant of SOD1-Dendra2, we observed that newly made mutant SOD1 was rapidly captured by pathologic intracellular inclusions. In cell models of mutant SOD1 aggregation over-expressing untagged A4V-SOD1, we observed that immature forms of the protein, lacking a Cu co-factor and a normal intramolecular disulfide, persist for extended periods. Our findings fit with a model in which immature forms of mutant A4V-SOD1, including newly made protein, are prone to misfolding and aggregation.
© 2016 International Society for Neurochemistry.

Entities:  

Keywords:  aggregation; amyotrophic lateral sclerosis; live imaging; oxidation; superoxide dismutase 1

Mesh:

Substances:

Year:  2016        PMID: 27727458      PMCID: PMC5283795          DOI: 10.1111/jnc.13864

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  47 in total

1.  Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form.

Authors:  Aaron Kerman; Hsueh-Ning Liu; Sidney Croul; Juan Bilbao; Ekaterina Rogaeva; Lorne Zinman; Janice Robertson; Avijit Chakrabartty
Journal:  Acta Neuropathol       Date:  2010-01-29       Impact factor: 17.088

Review 2.  ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration.

Authors:  John M Ravits; Albert R La Spada
Journal:  Neurology       Date:  2009-09-08       Impact factor: 9.910

3.  Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement.

Authors:  N Shibata; A Hirano; M Kobayashi; T Siddique; H X Deng; W Y Hung; T Kato; K Asayama
Journal:  J Neuropathol Exp Neurol       Date:  1996-04       Impact factor: 3.685

4.  Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis.

Authors:  Lawrence J Hayward; Jorge A Rodriguez; Ji W Kim; Ashutosh Tiwari; Joy J Goto; Diane E Cabelli; Joan Selverstone Valentine; Robert H Brown
Journal:  J Biol Chem       Date:  2002-02-19       Impact factor: 5.157

5.  Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS.

Authors:  Jiou Wang; George W Farr; Caroline J Zeiss; Diego J Rodriguez-Gil; Jean H Wilson; Krystyna Furtak; D Thomas Rutkowski; Randal J Kaufman; Cristian I Ruse; John R Yates; Steve Perrin; Mel B Feany; Arthur L Horwich
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

6.  Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag--implications for research into amyotrophic lateral sclerosis (ALS).

Authors:  James C Stevens; Ruth Chia; William T Hendriks; Virginie Bros-Facer; Jan van Minnen; Joanne E Martin; Graham S Jackson; Linda Greensmith; Giampietro Schiavo; Elizabeth M C Fisher
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

7.  Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature.

Authors:  Jiou Wang; Hilda Slunt; Victoria Gonzales; David Fromholt; Michael Coonfield; Neal G Copeland; Nancy A Jenkins; David R Borchelt
Journal:  Hum Mol Genet       Date:  2003-09-09       Impact factor: 6.150

8.  Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1.

Authors:  L I Bruijn; M K Houseweart; S Kato; K L Anderson; S D Anderson; E Ohama; A G Reaume; R W Scott; D W Cleveland
Journal:  Science       Date:  1998-09-18       Impact factor: 47.728

9.  Initiation and elongation in fibrillation of ALS-linked superoxide dismutase.

Authors:  Madhuri Chattopadhyay; Armando Durazo; Se Hui Sohn; Cynthia D Strong; Edith B Gralla; Julian P Whitelegge; Joan Selverstone Valentine
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-20       Impact factor: 11.205

10.  Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SOD(G93A) mice co-expressing the Copper-Chaperone-for-SOD.

Authors:  Jared R Williams; Emiliano Trias; Pamela R Beilby; Nathan I Lopez; Edwin M Labut; C Samuel Bradford; Blaine R Roberts; Erin J McAllum; Peter J Crouch; Timothy W Rhoads; Cliff Pereira; Marjatta Son; Jeffrey L Elliott; Maria Clara Franco; Alvaro G Estévez; Luis Barbeito; Joseph S Beckman
Journal:  Neurobiol Dis       Date:  2016-01-27       Impact factor: 5.996

View more
  7 in total

1.  Toxic SOD1 trimers are off-pathway in the formation of amyloid-like fibrils in ALS.

Authors:  Brianna Hnath; Nikolay V Dokholyan
Journal:  Biophys J       Date:  2022-05-03       Impact factor: 3.699

2.  Experimental Mutations in Superoxide Dismutase 1 Provide Insight into Potential Mechanisms Involved in Aberrant Aggregation in Familial Amyotrophic Lateral Sclerosis.

Authors:  Anthony M Crown; Brittany L Roberts; Keith Crosby; Hilda Brown; Jacob I Ayers; P John Hart; David R Borchelt
Journal:  G3 (Bethesda)       Date:  2019-03-07       Impact factor: 3.154

3.  Tryptophan residue 32 in human Cu-Zn superoxide dismutase modulates prion-like propagation and strain selection.

Authors:  Anthony Crown; Luke McAlary; Eric Fagerli; Hilda Brown; Justin J Yerbury; Ahmad Galaleldeen; Neil R Cashman; David R Borchelt; Jacob I Ayers
Journal:  PLoS One       Date:  2020-01-30       Impact factor: 3.240

4.  Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises.

Authors:  Luke McAlary; Yee Lian Chew; Jeremy Stephen Lum; Nicholas John Geraghty; Justin John Yerbury; Neil R Cashman
Journal:  Front Cell Neurosci       Date:  2020-11-04       Impact factor: 5.505

5.  Peripheral administration of SOD1 aggregates does not transmit pathogenic aggregation to the CNS of SOD1 transgenic mice.

Authors:  Isil Keskin; Elaheh Ekhtiari Bidhendi; Matthew Marklund; Peter M Andersen; Thomas Brännström; Stefan L Marklund; Ulrika Nordström
Journal:  Acta Neuropathol Commun       Date:  2021-06-22       Impact factor: 7.801

6.  Implications of fALS Mutations on Sod1 Function and Oligomerization in Cell Models.

Authors:  Aline A Brasil; Rayne S S Magalhães; Mariana D C De Carvalho; Isabel Paiva; Ellen Gerhardt; Marcos D Pereira; Tiago F Outeiro; Elis C A Eleutherio
Journal:  Mol Neurobiol       Date:  2017-09-07       Impact factor: 5.590

Review 7.  The Role of Metal Binding in the Amyotrophic Lateral Sclerosis-Related Aggregation of Copper-Zinc Superoxide Dismutase.

Authors:  Ivana Sirangelo; Clara Iannuzzi
Journal:  Molecules       Date:  2017-08-29       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.